SCHEMBL7398102

SCHEMBL7398102

Cc1ccc(N2CCN(C(=O)CC3OCCc4cc(Br)ccc43)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 7/20 0.44
DRD2 P14416 5/20 0.44
HTR2A P28223 5/20 0.44
HTR1A P08908 3/20 0.44
DRD4 P21917 2/20 0.44
AKR1C3 P42330 2/20 0.43
HTR1B P28222 1/20 0.43
HTT P42858 1/20 0.40
GFER P55789 1/20 0.40
SLC6A4 P31645 1/20 0.40
MAPT P10636 7/20 0.39
GAA P10253 2/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8591793 0.90 HTR1D (0.43) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL8591794 0.90 HTR1D (0.43) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL7404888 0.90 AKR1C3 (0.46) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL7403199 0.90 MAPT (0.51) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL8590591 0.89 DRD2 (0.57) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL8590585 0.89 DRD2 (0.57) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL8591792 0.89 DRD2 (0.57) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL8593155 0.88 HTR1D (0.47) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL8592577 0.88 HTR1D (0.47) HTR1DDRD2HTR2AHTR1ADRD4
SCHEMBL8592579 0.88 HTR1D (0.47) HTR1DDRD2HTR2AHTR1ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed